Table 2.
Serum sodium concentrationa, mmol/L |
|||||
---|---|---|---|---|---|
study population | female ECPFF | female ICPFF | male ECPFF | male ICPFF | |
At admission | 138.9 ± 3.6 | 139 ± 3.4 | 138.7 ± 4.0 | 138.7 ± 3.6 | 139.7 ± 3.4 |
Presurgery day | 138.5 ± 3.8 | 138.6 ± 4 | 138.3 ± 3.8 | 138.4 ± 3.3 | 138.9 ± 3.2 |
Postsurgery days | 139.4 ± 3.8 | 139.4 ± 3.2 | 138.9 ± 4.6 | 140.1 ± 4.1 | 139.4 ± 3.3 |
At discharge | 139.9 ± 4.6 | 140.5 ± 3.9 | 139.4 ± 4.1 | 139.5 ± 6.6 | 140.3 ± 3.3 |
Mean total | 139 ± 3.9 | 139.2 ± 3.7 | 138.7 ± 4.1 | 139.1 ± 4.3 | 139.5 ± 3.4 |
Prevalence of hyponatremia |
|||||
---|---|---|---|---|---|
study population | female ECPFF | female ICPFF | male ECPFF | male ICPFF | |
At admission | 9% | 8% | 11% | 10% | 5% |
Presurgery day | 13% | 14% | 17% | 9% | 8% |
Postsurgery days | 6% | 6% | 9% | 0% | 8% |
At discharge | 10% | 8% | 6% | 19% | 10% |
Mean total | 10% | 9% | 11% | 9% | 8% |
ECPFF, extracapsular proximal femoral fracture; ICPFF, intracapsular proximal femoral fracture.
Expressed as mean ± SD.